Perry F E, Barker R N, Mazza G, Day M J, Wells A D, Shen C R, Schofield A E, Elson C J
Department of Pathology and Microbiology, University of Bristol, GB.
Eur J Immunol. 1996 Jan;26(1):136-41. doi: 10.1002/eji.1830260121.
Splenic T cells from Coombs'-positive New Zealand Black (NZB) mice proliferated consistently in vitro in response to the integral red blood cell (RBC) membrane protein Band 3, the antigen previously shown to be the target for the pathogenic RBC autoantibodies. The responding cells predominantly express CD4 and the proliferative response is blocked by antibodies to the NZB major histocompatibility complex class II but not by antibodies to an irrelevant H-2 haplotype. NZB splenic T cells also proliferated in response to the internal membrane skeleton protein spectrin. By contrast, T cells from BALB/c and DBA2 mice, which bear the same H-2 haplotype as NZB mice, but which do not develop autoimmune hemolytic anemia (AIHA), fail to respond to Band 3. It is considered that these results support the hypothesis that Band 3-reactive T cells provide help for the production of pathogenic anti-Band 3 autoantibodies in NZB mice. T cells from Coombs'-negative NZB mice as young as 3 weeks old proliferated in response to Band 3; moreover, the RBC from Coombs'-negative mice bore elevated levels of autoantibody as judged by a sensitive direct enzyme-linked anti-globulin test. Thus, the pathology of AIHA develops at a much earlier age than was thought previously.
来自抗人球蛋白试验阳性的新西兰黑鼠(NZB)的脾T细胞,在体外能持续增殖,以响应完整红细胞(RBC)膜蛋白带3,该抗原先前已被证明是致病性RBC自身抗体的靶标。反应细胞主要表达CD4,且增殖反应被针对NZB主要组织相容性复合体II类的抗体阻断,但不被针对无关H-2单倍型的抗体阻断。NZB脾T细胞也能响应内膜骨架蛋白血影蛋白而增殖。相比之下,与NZB小鼠具有相同H-2单倍型但不发生自身免疫性溶血性贫血(AIHA)的BALB/c和DBA2小鼠的T细胞,对带3无反应。据认为,这些结果支持这样的假说,即带3反应性T细胞为NZB小鼠中致病性抗带3自身抗体的产生提供帮助。来自3周龄抗人球蛋白试验阴性的NZB小鼠的T细胞,对带3有增殖反应;此外,通过敏感的直接酶联抗球蛋白试验判断,抗人球蛋白试验阴性小鼠的RBC携带的自身抗体水平升高。因此,AIHA的病理发展比先前认为的要早得多。